MyAverix Finance
NS · Pharmaceuticals
Lasa Supergenerics Ltd (LASA)
Pharmaceuticals & Biotechnology
Lasa Supergenerics Ltd (LASA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $373.30M, P/E ratio is -1.11, net margin is -55.1%, dividend yield is 3.36%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LASA
Lasa Supergenerics Ltd (LASA) — FAQ
What is Lasa Supergenerics Ltd's market cap?
Lasa Supergenerics Ltd (LASA) has a reported market cap of $373.30M (data as of 2026-07-10).
What is LASA's P/E ratio?
The price-to-earnings (P/E) ratio for Lasa Supergenerics Ltd (LASA) is -1.11 (data as of 2026-07-10).
Does Lasa Supergenerics Ltd pay a dividend?
Lasa Supergenerics Ltd (LASA) shows a reported dividend yield of 3.36%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Lasa Supergenerics Ltd in?
Lasa Supergenerics Ltd (LASA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is LASA listed on?
LASA is listed on NS.
What is Lasa Supergenerics Ltd's net margin?
Lasa Supergenerics Ltd (LASA) reports a net margin of -55.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.